IFGLEXPOR NSI Week ended 07 Aug 2026

Weekly Investor Report

IFGL Refractories Limited · Basic Materials · Building Materials

Open interactive chart View report data
Latest close 227.1 INR
7.1% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 24.6% above the Trend Line and sits at 49.2% of its 52-week range. The latest completed week returned 7.1%, after a -0.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100.

Setup score 50 out of 100
Latest Close 227.1 INR 7 Aug 2026
1W Return 7.1% latest completed week
4W Return -0.6% short-term follow-through
12W Return 37.0% quarterly tape
Trend Breadth 34.6% 18 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.1% Latest completed week; four-week move -0.6%. Indicator stack 36/68 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 51/100 21 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 24.6% above the Trend Line and sits at 49.2% of its 52-week range. The latest completed week returned 7.1%, after a -0.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4212-week average 0.21

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.42Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -0.6% over four weeks, 37.0% over 12 weeks, and -1.5% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W7.1%
4W-0.6%
12W37.0%
26W24.5%
52W-1.5%
Active trend streak5 weeks
Active weeks in one year18
Trend breadth34.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.05Latest activity-pressure read.
Pressure change-14.9%Four-week change in activity pressure.
Leadership12.01Latest relative-leadership reading.
RS change-7.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength50/100Blend of value, momentum, and quality. Underlying universe rank 51; rank 1 is best.
Value66/100Relative valuation strength. Underlying universe rank 35; rank 1 is best.
Quality30/100Profitability and accounting quality. Underlying universe rank 71; rank 1 is best.
Momentum39/100Medium-term price momentum. Underlying universe rank 62; rank 1 is best.
Growth29/100Revenue and earnings growth. Underlying universe rank 72; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework21/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
47.2x
Price divided by trailing earnings.
Price / sales
0.9x
Market value relative to trailing revenue.
EV / EBITDA
12.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
47.8%
Gross profit retained from each unit of revenue.
Operating margin
3.0%
Operating profit retained from revenue.
Free-cash-flow margin
-0.0%
Free cash flow generated from revenue.
Return on invested capital
3.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
14.9%
Latest one-year revenue growth.
EPS growth
-19.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.9%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 21 relevant articles.

1 positive · 20 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-32.8%Distance below the 52-week high.
13-week volatility8.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+28.2%Week of 10 Apr.
Worst week-12.4%Week of 15 May.
Latest week+7.1%Week of 7 Aug.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks0
Modest losses4
Sharp losses9
Recent vol8.5%13-week weekly-return volatility.
Base vol7.6%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew6.6% / -4.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape46/100

Trend, activity pressure, participation, and risk combine to a 46/100 tape read.

 Indicator analysis55/100

Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 5/12.

Activity pressure 0.42; No reversal markers Factors45/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 37; Small Cap Core rank 34 SVQF21/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 1248.0 of 1576 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 21 relevant articles.

IFGL Refractories recommends ₹2.15 dividend for FY26 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026227.1 INR7.1%182.2 INR249.5 INR1.0512.01452.1KOn
31 Jul 2026211.9 INR8.4%181.2 INR249.5 INR1.175.28254.8KOn
24 Jul 2026195.5 INR-7.0%181.2 INR249.6 INR1.34-0.61192.7KOn
17 Jul 2026210.3 INR-8.0%181.5 INR249.5 INR1.344.02204.7KOn
10 Jul 2026228.5 INR4.3%181.4 INR249.3 INR1.2312.961.5MOn
3 Jul 2026219.0 INR19.4%180.8 INR249.1 INR0.947.562.2MOff
26 Jun 2026183.5 INR-4.8%180.3 INR248.7 INR0.69-9.480Off
19 Jun 2026192.7 INR2.7%181.4 INR248.6 INR0.66-5.3421.6KOff
12 Jun 2026187.7 INR-3.6%182.3 INR248.4 INR0.56-6.6726.5KOff
5 Jun 2026194.8 INR11.5%183.9 INR248.2 INR0.46-2.5944.1KOff
29 May 2026174.7 INR3.0%185.2 INR247.9 INR0.61-13.73121.0KOff
22 May 2026169.6 INR2.3%187.7 INR247.7 INR0.74-17.45145.1KOff
15 May 2026165.8 INR-12.4%190.5 INR247.6 INR0.91-19.54110.3KOff
8 May 2026189.3 INR-0.3%193.5 INR247.3 INR1.00-10.66318.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context